New Stock News | China's largest candy company, Amos, submitted its application to the Hong Kong Stock Exchange with a three-year compound annual growth rate of over 109%.
According to the disclosure by the Hong Kong Stock Exchange on April 28th, Aymes Food Group Limited (referred to as Aymes) has submitted its listing application to the main board of the Hong Kong Stock Exchange. Bank of America Securities, CMB International Securities, and J.P. Morgan are joint sponsors for the company.
According to the disclosure on April 28th by the Hong Kong Stock Exchange, Amos Food (Group) Co., Ltd. (referred to as Amos) submitted its listing application to the Hong Kong Stock Exchange main board, with Bank of America Securities, CMSC International, and J.P. Morgan as its joint sponsors. According to Frost & Sullivan data, based on the retail sales in 2025, the company is the largest candy company in China and the fifth largest gummy candy company globally.
According to the prospectus, the company is a leading global candy company engaged in the design, development, manufacturing, and sales of candies aimed at delivering happiness and health. The company mainly markets its products under two major brands (Amos and Beobeo).
As an innovator in the traditional candy landscape, the company focuses on high-growth segments of happiness and health and is rapidly expanding the global reach of its creative candy brands Amos and nutritious candy brand Beobeo. The company was listed in the prestigious Global Top 100 Confectionery Companies in 2026, confirming its industry-leading position. According to Frost & Sullivan:
Based on the retail sales in 2025, the company is the largest candy company in China and the fifth largest gummy candy company globally.
Based on the retail sales from 2023 to 2025, the company is one of the fastest-growing companies among the top 30 confectionery companies globally, with a compound annual growth rate of 61.9%, compared to the industry average of 5.9% during the same period.
Based on overseas revenue in 2025, the company holds the largest market share among all Chinese candy companies in the overseas market.
The company's creative candy brand Amos injects new vitality into the traditional candy landscape through a focus on product innovation within its category. Amos represents sweet moments, smiling moments, sharing moments, and sincere moments, and was rated by authoritative consumer data analysis agency Numerator as the most rapidly growing brand in the U.S. market in 2025, being the only candy brand selected. With a comprehensive R&D framework and highly scalable product development and channel execution capabilities, the company leads in transforming innovative product concepts into flexible and customized product manufacturing, either in large or small-scale production. This innovation-driven approach from concept to shelf has led to a successful portfolio of top-selling products in retail channels and consumer groups, including:
Peelerz gummy candy: The company redefined the consumer experience with its unique texture and interactive peeling experience through its signature fruit-shaped mango-flavored peeler gummy candy.
4D (3D+Delicious) block gummy candy: By introducing fun and stackable block gummy candies in fruit and animal shapes, the company successfully created a new category of gummy candies.
Festive candies: Over the years, the company's festive candy products for Chinese New Year, Valentine's Day, Easter, Halloween, Christmas, etc., have maintained steady growth in sales in major global retail chains and e-commerce platforms.
Yinfu voice lollipops: This includes music lollipops and other cultural content lollipops, demonstrating the company's ability to integrate cultural elements and technology into candy, achieving cross-border innovation.
Based on the success in the creative candy segment and witnessing a shift towards health-oriented consumption, the company launched Beobeo, a brand focused on the future high-growth nutrition and better-for-you candy segment. As a pioneer in the Chinese active probiotic gummy candy industry, Beobeo bridges the gap between happiness and health through scientifically-based formulas. Beobeo's commercial viability and R&D capabilities benefit from its stable performance and industry recognition. According to Frost & Sullivan data, its probiotic gummy candy ranked first among similar products in China in terms of retail price in 2025. With these cross-category accolades and the global health trend driving, Beobeo has attracted a rapidly growing mature consumer group with its health advantages and is positioned as the company's second growth engine.
The global candy market is vast and highly fragmented, with a stable consumer base and broad cross-market appeal. According to Frost & Sullivan data, the global candy market was estimated to be approximately RMB 538.1 billion in 2025, and is expected to reach approximately RMB 703.3 billion by 2030.
In terms of performance, the company has entered an explosive period, with revenues of approximately RMB 1.07 billion, RMB 1.571 billion, and RMB 2.782 billion in 2023, 2024, and 2025 respectively, with a compound growth rate of approximately 61.2%; during the same period, profits were approximately RMB 137 million, RMB 198 million, and RMB 600 million, with a compound growth rate of approximately 109.3%, significantly outperforming the revenue growth rate.
Related Articles

MICROPORT NEURO (02172) spent approximately HK$1.0348 million to repurchase 100,000 shares on April 29th.

Hansoh Pharma (03692): B7-H3 targeted antibody-drug conjugate HS-20093 approved as breakthrough therapy for castration-resistant prostate cancer.
.png)
Chongqing Sokon Industry Group Stock (09927) reported a first quarter net profit attributable to the parent company of 754 million yuan, an increase of 0.89% year-on-year.
MICROPORT NEURO (02172) spent approximately HK$1.0348 million to repurchase 100,000 shares on April 29th.

Hansoh Pharma (03692): B7-H3 targeted antibody-drug conjugate HS-20093 approved as breakthrough therapy for castration-resistant prostate cancer.

Chongqing Sokon Industry Group Stock (09927) reported a first quarter net profit attributable to the parent company of 754 million yuan, an increase of 0.89% year-on-year.
.png)
RECOMMEND





